
New study explores urinary management in people with spinal cord injury
Rethink Medical has contributed to a new study published in Revista ENFURO exploring urinary management and unmet needs among people with spinal cord injury.

We are thrilled to announce that our T-Control® urinary catheter has officially received the CE Mark, certifying its compliance with European safety and performance standards.
This milestone is the result of years of dedication and research, guided by our mission to develop medical devices around patient experience, healthcare-professional needs and responsible use of healthcare resources.
Designed with real clinical practice in mind, T-Control® provides a unique solution to address key challenges associated with one of the most widely used medical devices: the urinary catheter.
A heartfelt thank you to our team, partners, and collaborators who made this achievement possible — we’re just getting started!

Rethink Medical has contributed to a new study published in Revista ENFURO exploring urinary management and unmet needs among people with spinal cord injury.

Rethink Medical participated in the 48th Congress of the Spanish Neuroscience Nursing Association, sharing the journey from identifying an unmet need in clinical practice to developing a regulated medical device.

Rethink Medical reached the minimum target of its 2026 investment round ahead of the initially planned closing date.